Schedule 13G ownership disclosure

Aura Biosciences Inc

Common Stock, par value $0.00001 per share · CUSIP: 05153U107

Event date: 2025-04-04

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • SUVRETTA CAPITAL MANAGEMENT, LLC

    Shares: 3,057,319.00 · Class: 6.1%

  • Averill Master Fund, Ltd.

    Shares: 2,695,810.00 · Class: 5.4%

  • Aaron Cowen

    Shares: 3,057,319.00 · Class: 6.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-002448
Form type
SCHEDULE 13G
Filer
Aura Biosciences, Inc.
CIK
CIK 1501796
Filed
Apr 11, 2025
Reporting period
Apr 04, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub